This study aimed to investigate the effect of bioactive glasses on cutaneous wound healing in both normal rats and streptozotocin-induced diabetic rats. Bioactive glass ointments, prepared by mixing the sol-gel bioactive glass 58S (SGBG-58S), nanobioactive glass (NBG-58S) and the melt-derived 45S5 bioactive glass (45S5) powder with Vaseline (V) at 18% weight percentage, were used to heal full thickness excision wounds. Pure V was used as control in this study. Compared to SGBG-58S, NBG-58S consists of relatively dispersible nanoparticles with smaller size. The analysis of wound healing rate and wound healing time showed that bioactive glasses promoted wound healing. The ointments containing SGBG-58S and NBG-58S healed the wounds more quickly and efficiently than the ointment containing 45S5. Histological examination indicated that bioactive glasses promoted the proliferation of fibroblasts and growth of granulation tissue. Immunohistochemical staining showed that the production of two growth factors, VEGF and FGF2, which are beneficial to wound healing, was also stimulated during the healing process. Transmission electron microscope observations showed that fibroblasts in wounds treated with bioactive glasses contained more rough endoplasmic reticula and had formed new capillary microvessels by the seventh day. The effects of SGBG-58S and NBG-58S were better than those of 45S5. All results suggest that bioactive glasses, especially SGBG-58S and NBG-58S, can accelerate the recovery of skin wounds in both normal and diabetes-impaired healing models and have a great potential for use in wound repair in the future.
Introduction
As the prevalence of diabetes mellitus (DM) is rapidly increasing in many countries, diabetic complications have become a serious issue for public health. One of these complications is the impaired wound healing experienced by diabetic patients [1] . Because of the persistence of inflammatory cells, the disordered synthesis and remodelling 4 Author to whom any correspondence should be addressed.
of extracellular matrix (ECM), as well as the failed re-epithelialization, the healing conditions of diabetic wounds are not optimal [2, 3] . Although often viewed as a potential therapy to improve healing, the topical application of growth factors has met with limited success for many reasons such as their high diffusibility and very short half-life [4, 5] . Many skin substitutes such as xenografts, allografts and autografts have been used for the treatment of deep partial-and full-thickness wounds. However, due to their antigenicity or the limited availability of donor sites, skin substitutes cannot accomplish the purpose of skin regeneration and hence are not widely used [6] . Nowadays, very few skin substitutes available or under development are able to fully substitute for natural living skin [7] . As a result, the development of a new wound healing enhancer would be an important advance in this field.
Bioceramics are special compositions of ceramic materials in the form of powders, coatings or bulk devices that are used to repair, augment or replace diseased or damaged tissues. Bioactive glasses are usually used for the replacement of ear bones, teeth or vertebrae or as powders to repair bone [8, 9] . The base components in most bioactive glasses, made by traditional high-temperature melting, casting and sintering, are SiO 2 , Na 2 O, CaO and P 2 O 5 . The first and best studied composition is 45S5 Bioglass R , which contains 45% SiO 2 , 24.5% Na 2 O, 24.5% CaO and 6% P 2 O 5 , by weight per cent. The melt-derived bioactive glass 45S5 and the sol-gelderived bioactive glasses 58S and 77S are well-known types of biomaterials for use in bone repair and as bone tissue engineering scaffolds due to their high bioactivity [10, 11] . They can be chemically bound to bone and soft tissues through an apatite layer precipitated on glass surfaces exposed to the tissue with minimal inflammation and toxicity for the host for a period of time. The biological activity of 45S5 made by a melt-derived process has been studied extensively in relation to its ability to form stable and mechanically strong bonds with bone and soft connective tissues [12] .
The sol-gel method is a versatile technique to produce micro-and nano-sized bioactive glass particles by tuning the precipitation reaction. A micro-and nano-bioactive glass can be prepared using the sol-gel method [13] [14] [15] , for example, the glass designated 58S, with the composition (mol%) of 60 SiO 2 , 36 CaO, 4 P 2 O 5 [16] . Because of the nanopores within the glass, the sol-gel-derived bioactive glass has high surface area (100-200 m 2 g −1 ). As a result, they can degrade and convert to hydroxylapatite faster than the melt-derived glass with the same composition, which further improves the bioactivity [17] . Nanosurface and nanoparticles are known to influence cell behaviour and cell-material interactions [18] . However, the size of the traditional sol-gel-derived bioactive glass was about 1 μm due to poor dispersity [16] , while the size of the nanobioactive glass can be controlled to about 30 nm with high dispersity. Hence, the bioactivity of a nanobioactive glass may be better compared to a microphase bioactive glass [18] .
While bioactive glasses have been extensively investigated for bone repair and regeneration, there has been relatively little research on the application of bioactive glasses to repair or regenerate soft tissues. However, several studies have revealed that the 45S5 bioactive glass can also bond well with soft tissue and can promote the regeneration of soft tissue such as the skin [19] [20] [21] . Recent work has demonstrated the ability of a bioactive glass to promote angiogenesis, which is critical to numerous applications in tissue regeneration and the healing of soft tissue wounds [22] [23] [24] . Microarray analysis indicated that a bioactive glass can activate the expression of genes related to wound healing, such as the CD44 antigen hematopoietic form precursor, fibronectin receptor beta subunit, fibroblast growth factor receptor1 precursor (N-sam), vascular endothelial growth factor (VEGF) precursor and vascular cell adhesion protein 1 precursor (V-CAM 1) [25, 26] . The ability of bioactive glasses to induce angiogenesis could provide a robust alternative approach to the use of expensive growth factors for stimulating the neovascularization of impaired tissues.
In this study, we prepared three different kinds of bioactive glasses: 45S5 by the melting process, SGBG-58S and NBG-58S by the traditional and novel sol-gel process. We aimed to investigate whether these three types of bioactive glasses can promote the healing process of cutaneous wounds.
Materials and methods

Preparation and characterization of materials
Ethanol absolute (EA), tetraethyl orthosilicate (TEOS), triethylphosphate (TEP), calcium nitrate tetrahydrate (CN) and diammonium phosphate (DAP) were purchased from Guanghua Chemical Factory Co. Ltd (Shantou, People's Republic of China). All were analytical grade reagents. Deionized water was obtained from a water purification system (Millipore SAS, France).
The 45S5 bioactive glass (45S5) (weight compositions: 45% SiO 2 , 24.5% Na 2 O, 24.5% CaO and 6% P 2 O 5 ) was prepared by a melting process in this study by mixing the analytical reagent grades Na 2 CO 3 , CaCO 3 , Na 3 PO 4 and SiO 2 in an electric oven at 1400
• C for 2 h [27] . The 58S sol-gel bioactive glass (SGBG-58S) (weight composition: 58% SiO 2 , 33% CaO and 9% P 2 O 5 ) was prepared by the sol-gel method. Briefly, the sol was made by hydrolysis of TEOS, TEP and Ca(NO 3 ) 2 · 4H 2 O. After ageing the sol at 70
• C for three days followed by drying at 150
• C for two days, the gel was obtained. Later, the gel was heated for 2 h at 700
• C and became the sol-gel 58S bioglass [14] . The synthesis procedure for the nanobioactive glass (NBG-58S) (weight composition: 58% SiO 2 , 33% CaO and 9% P 2 O 5 ) was as follows [28] . First, TEOS (221.02 mL) and CN (138.68 g) were mixed with EA (162.21 mL, ethanol: deionized water = 1: 1) to form a solution, using hydrochloric acid to adjust the pH between 1 and 2 to form a sol. A DAP solution containing DAP (17.4 g) and deionized water was also prepared. Then the TEOS-CN-EA solution was slowly added to the DAP solution while stirring. Once the two solutions were completely mixed, a solution of ammonia (28%wt, a gelation catalyst) was added dropwise to the mixture until a white precipitate appeared. Finally, the bioactive glass was obtained after freeze-drying the sol-gel co-precipitate and heating at 600
• C. All three types of bioactive glasses were fabricated into particles with diameters less than 53 μm by grinding and sieving using a sieve shaker (Vibratory Sieve Shaker AS 200 control, Germany). The morphology of the bioactive glasses was observed using a scanning electron microscope (SEM, Tecnai12, FEI, The Netherlands) under an accelerating voltage of 10.0 kV. The bioactive glass ointments were then prepared by the following method: bioactive glass powders (18 wt%) were mixed with melted Vaseline (maintained at 80
• C) under vigorous stirring, then cooled and sterilized until they became ointments. . STZ-treated rats with whole-blood glucose levels above 16.7 mM were considered diabetic. The rats were fed a standard diet and maintained in the controlled environment of the animal centre at 25 ± 1
• C under a 12 h light-dark cycle. All animal procedures were approved by Wenzhou Medical College Animal Care and Use Committee, which is certified by the Chinese Association of Accreditation of Laboratory Animal Care.
Grouping and treatment of the full-thickness skin wound
rats. There were two sets of animal experiments. The first set of animal experiments was used to evaluate the healing effect of the bioactive glass in normal rats. Thirty-six normal rats were used and four wounds were created on the back of each rat. The rats were then divided into four groups according to the treatments of the three wounds on each rat. The four treatments were as follows. (1) SGBG-58S group: wounds were covered with bioactive glass ointment SGBG-58S; (2) NBG-58S group: wounds were covered with bioactive glass ointment NBG-58S; (3) 45S5 group: wounds covered with bioactive glass ointment 45S5; (4) control: wounds were covered with Vaseline. In the second set of animal experiments, 36 diabetic rats were used to test the therapeutic effect of the same two kinds of sol-gel-derived bioactive glass and meltderived 45S5 bioactive glass in diabetic rats, and the rats were also divided into four groups (SGBG-58S group, NBG-58S group, 45S5 group and control) according to the treatment of the four wounds on each rat.
Full-thickness skin wounds were created on the dorsum of the rats. Rats were anaesthetized using an intraperitoneal injection of pentobarbital sodium (30 mg kg −1 body weight), the dorsal hair of the rats was shaved with a clipper, and the exposed skin was disinfected with 70% ethanol and povidone iodine. Four full-thickness 1.8 cm diameter wounds were marked using a template, and the tissue was excised to the level of the fascia, using dissecting scissors and forceps. Then the wounds of each rat were treated with the different ointments described above. After applying a sample to each of the wounds, a sterilized elastic band (TegadermTM, 3M Health Care, Germany) was employed to wrap the treated animals, and a self-adhesive wrap (CobanTM, 3M Health Care) was employed to keep each sample in contact with the dorsum of the rat. The ointments were re-applied every other day and the treated rats were placed in individual cages.
Wound closure was measured every other day after wounding. Eight animals were euthanized at days 7 and 14. The tissue samples were harvested at 7 and 14 d post-surgery. All the tissue samples were cut in a full-thickness manner from the wounded sites, and then were used for histological analyses.
Measurement of wound healing.
Healing of the wounds was observed and recorded every other day using a digital camera. The degree of healing was expressed as wound healing rate = (A 0 −A t )/A 0 × 100%, where A 0 and A t represent the initial wound area and the wound area at time t, respectively. In order to determine the healing of the wound, the residual wound margin was traced onto a transparent film every other day after surgery. The labelled tracing film was scanned (MRS-4800U2, Microtek, Beijing), and the wound area was calculated using image analysis software (Image-Pro plus, Media Cybernetics, Bethesda, MD). A wound was considered healed when it was covered with new epidermis [29] .
Histological analysis and immunohistochemistry
Rats were sacrificed on days 2, 7 and 14 after various treatments. The wound samples were fixed in paraformaldehyde and embedded in paraffin. Skin tissues were cut into 5 μm sections for histopathological examination by hematoxylin-eosin (H&E) staining and for immunohistochemical staining of the basic fibroblast growth factor (bFGF) and VEGF. Paraffinembedded sections were deparaffinized and rehydrated, and then were washed with water and stained with H&E.
For immunohistochemical staining, the deparaffinized and rehydrated tissue sections were incubated with 3% H 2 O 2 for 10 min. To recover the antigen, these sections were put into a 10 mM citrate buffer solution (pH 6.0) and heated twice in a microwave oven. The slides were then washed twice with phosphate buffered saline (PBS) (pH 7.2-7.6). Non-specific binding sites were blocked with 5% bovine serum albumin (BSA) in TBS for 20 min. After the blocking solution was poured off, the sections were incubated with mouse anti-VEGF primary antibody (1:50, Santa Cruz Biotechnology, USA) or rabbit anti-FGF2 primary antibody (1:100, Santa Cruz Biotechnology, USA) at 4
• C overnight, then washed with PBS. The slides were then incubated with biotinylated goat anti-mouse secondary antibodies or goat anti-rabbit secondary antibody (1:200, Santa Cruz Biotechnology, USA) for 20 min, followed by incubation with streptavidin-HRP for 20 min. Both the first and secondary antibodies were diluted with PBS. The antibody binding sites were visualized by incubation with a diaminobenzidine (DAB)/H 2 O 2 solution. The slides were counterstained for 1 min with hematoxylin and then dehydrated through sequential ethanol for sealing and microscopic observation. H&E-and immunohistochemicalstained sections were observed with a Zeiss 40FL Axioskop fluorescent microscope. 
Transmission electron microscopy observations
For TEM observation, samples containing a portion 2 mm from the edge of the incision were immediately fixed in 0.1 M phosphate buffer containing 2.5% glutaraldehyde and 2% paraformaldehyde for 4 h. The samples were then fixed again with 1% osmium tetroxide for 2 h, routinely dehydrated through a graded ethanol series, and embedded in epoxy resin. Resin-embedded blocks were cut into 60-80 nm ultrathin sections with an ultra-microtome. The ultrathin sections were placed on carbon-coated nickel grids and examined with an H-600 TEM (H-600, Tokyo, Japan) operating at 80 kV.
Statistical analysis
Data are expressed as mean ± standard deviation. Statistical analysis was performed by two-tailed Student's t-tests between two groups or by one-way ANOVA between more than two groups. All statistical computations were performed using SPSS version 16.0 (SPSS Inc., Chicago, IL). The significance level was set at p < 0.05.
Results
Characterization of the bioactive glasses
The loose powder NBG-58S can be obtained right after heat treatment, while the particles of SGBG-58S need to be ground to become powdery and then sieved before use. The surface morphology and microstructure of bioactive glass particles examined by SEM are shown in figure 1 . The melting 45S5 bioactive glass appears to be irregular bulks and shows a dense surface with no nano-particles ( figure 1(a) ). In contrast, SGBG-58S has a nano-porous surface composed of a large number of nano-microspheres, about 60 nm in diameter ( figure 1(b) ). However, due to the aggregation of the particles, the size of the SGBG-58S can reach 1 μm (data not supplied).
Compared to SGBG-58S, NBG-58S (figure 1(c)) consists of relatively dispersible nanoparticles (about 30 nm in diameter), which can also be confirmed by the TEM image with higher dispersity than SGBG-58S ( figure 1(d) ).
Wound healing performance and gross examination of the healing process
The weight and blood glucose levels of the diabetic rats were measured before and 14 days after injection of STZ. The rats were significantly hyperglycemic (p < 0.01) and showed a decrease in body weight during this period (p < 0.05), indicating that DM was successfully induced in the rats (figure 2). The wound healing times for diabetic wounds treated by SGBG-58S, NBG-58S, 45S5 and control were 12.75 ± 0.37, 14 ± 0.53, 14.75 ± 0.65 and 16.75 ± 0.65 days, respectively, and are shown in figure 3(a1) . Compared to the control group, wound healing times of the bioactive glass groups were significantly reduced (p < 0.05). Among the experimental groups it was evident that the healing time of the SGBG-58S group was shorter than the 45S5 group (p < 0.05) or NBG-58S group, although there was no significant difference between the SGBG-58S and the NBG-58S groups. As for the normal rats treated by SGBG-58S, NBG-58S, 45S5 and control, wound healing times were 10.75 ± 0.36, 11.75 ± 0.36, 12.12 ± 0.26 and 13.63 ± 0.47 days, respectively, and the healing times of the bioactive glass groups were significantly shorter than the control group ( figure 3(a2) ). Moreover, the healing times of wounds treated by the same SGBG-58S, NBG-58S, 45S5 and Vaseline in normal rats were significantly shorter than for diabetic rats (p < 0.05). Wound healing rates of the wounds treated by different methods are shown in figures 3(b1) and (b2). By observing the wound area at defined time intervals, the reduction in wound defect area was calculated. In the case of the diabetic bioactive glass groups, the healing processes were rapid, with more than 50% wound closure achieved in the first six days, and about 90% wound closure achieved within ten days. The healing of the control group was slower than any of the bioactive glass groups, and the differences were statistically significant (p < 0.05). The wound healing effect of SGBG-58S was the fastest among all four groups, followed by the NBG-58S group ( figure 3(b1) ). However, there were no significant differences between NBG-58S and 45S5. These results are consistent with the results of wound healing times ( figure 3(a1) ). The wound healing rates in normal rats were similar to the diabetic rats, but with higher rates at each time point ( figure 3(b2) ). Based on the wound healing time and healing rate of the diabetic rats, we concluded that the three types of bioactive glasses can accelerate wound healing in both normal and diabetic rats. In addition, the healing effect of the sol-gel bioactive glasses (SGBG-58S, NBG-58S) was better than the melt-derived 45S5 bioactive glass.
Representative images of the wound healing process in diabetic wounds treated with SGBG-58S, 45S5, NBG-58S and Vaseline at days 0, 2, 4, 8, 12 and 16 after surgery are shown in figure 4. On day 2, there were no significant changes in wound size compared to day 0 of each group. On day 4, wound shrinkage was observed in the bioactive glass groups, with a yellow membranous layer adhering to the surface of the wound. The wounds were rough and filled with obviously visible granulation tissue, and the visible transparent epidermis grew and extended towards the centre of the wound (figures 4(a3), (b3) and (c3)). The wounds of the control group were smooth, and no granulation tissue or epidermis was visible ( figure 4(d3) ). On day 8, the wound sizes in the bioactive glass groups were significantly reduced. The thickness of the granulation tissue was close to that of normal skin, and the colour of the wound started to change from bright red to pink (figures 4(a4), (b4) and (c4)). The wounds of the control group also began to shrink, and the thickness of granulation tissue increased, but it did not fill the wounds completely ( figure 4(d4) ). By days 10-12, the colour of the wounds in the control group started to change to pink, but wound healing was still low ( figure 4(d5) ). At 14-16 d, the wounds were almost completely healed in the bioactive glass groups, while in the control group, open wounds could still be seen in most of the animals (figures 4(a6), (b6), (c6) and (d6)).
Histological analysis
Histological analyses were performed to assess the regenerated tissues guided by different types of bioactive glasses in both normal and diabetic rats, and the results are presented in figures 5 and 6. During the early stage of the healing process (days 2-4), we found that there was a rough, yellow loose surface layer on top of the wounds in all bioactive glass groups (both the normal and diabetic rats), and it was further confirmed through H&E staining that it consisted of a large number of inflammatory cells, bioactive glass granules and various secretions ( figure 5(a) ). In the diabetic group, at day 7, there was a typical infiltration of granulocytes in all the groups. Macrophages could also be observed at this stage ( figure 5(b) ) and the implanted bioactive glasses could be clearly distinguished from the host tissues. Interestingly, a long channel could be seen behind the bioactive glass particles. Compared to a few infiltrated fibroblasts in the control group (figure 6(d1)), the fibroblasts had infiltrated the bioactive glasses, and a large number of blood vessels could be observed in the bioactive glass groups (figures 6(a1), (b1) and (c1)). In the control group, there were still a larger number of inflammatory cells and fewer blood vessels appearing in the tissue. In the normal group, while inflammatory cells were still observed in the control group (figure 6(n-d1)), the healing conditions of the bioactive glass groups (figures 6 (n-a1), (n-b1) and (n-c1)) were better than the diabetic group with fewer inflammatory cells, more fibroblasts and blood vessels. At day 14, the numbers of granulocytes had almost disappeared in all the groups except the controls of the diabetic group in which a few macrophages could still be observed ( figure 6(d2) ). The bioactive glasses had almost disappeared and the wounds were almost healed in these groups. Specifically, in the diabetic group, newly formed definitive epithelium could be seen in the SGBG-58S and NBG-58S groups with abundant collagen (figure 6(b2) and (c2)), while this did not occur in the 45S5 group ( figure 6(a2) ). However, in the normal group, the wounds were healed in all three categories and newly formed epithelium could be observed covering the wounds completely with abundant collagen (figures 6(n-a2), (n-b2), (n-c2) and (n-d2)).
Immunohistochemistry
To evaluate the presence of VEGF in the novel bioactive glass-treated wounds, immunohistochemical staining was performed, and the results are displayed in figure 7. Positive staining for VEGF was observed in all the tissue samples regardless of the implantation time, but its level depended greatly on the health of the rats, the bioactive glass used and the treatment time. At day 7, in the diabetic group, the regenerated tissues of the bioactive groups showed more abundant VEGF than the control group. Moreover, more blood vessels could be seen in both the SGBG-58S and NBG groups (figures 7(b1), (c1) and (d1)). However, in the normal rats, the expression of VEGF in the bioactive groups was lower than in the control group (figures 7(n-b1), (n-c1) and (n-d1)). Comparatively, at this stage the samples of the bioactive glass groups in the diabetic rats showed stronger positive staining than those in the normal rats. After treatment for 14 days, all the groups showed positive staining (figures 7(b2), (c2) and (d2)). Specifically, the diabetic group showed less expression of VEGF than on day 7 (figures 7(b2), (c2) and (d2)). The same phenomenon was observed in the normal group, with fewer cells expressing VEGF than the normal rats (figures 7(n-b2), (n-c2) and (n-d2)).
Immunochemical staining of wound skin for the expression of FGF2 was also performed at days 7 and 14. At day 7, strong positive staining was observed in all the tissue samples. In the diabetic group, the newly formed tissues of the bioactive groups showed more abundant FGF2 than the control group. However, the expression of FGF2 in the normal group (figures 8(n-b1), (n-c1) and (n-d1)) was slightly less than in the diabetic group (figures 8(b1), (c1) and (d1)). After treatment for 14 days, all the groups showed strong positive staining, especially in the diabetic groups (figures 8(b2), (c2) and (d2)) and the control rats of the normal groups, which was consistent with the expression of VEGF at days 7 and 14 (figures 8(n-b2), (n-c2) and (n-d2)).
TEM examination
From the results of H&E staining and immunohistochemistry, we knew that at day 7 all the groups had regenerated new blood vessels with a few inflammatory cells and lots of fibroblasts. Due to the difficult healing of diabetic wounds, we investigated the early response of diabetic wounds treated with different bioactive glasses. TEM images of ultrathin sections of skin tissue from the diabetic rats are shown in figure 9 . On day 2, a small number of new fibroblasts and large numbers of inflammatory cells could be seen in the bioactive glass groups but a very small number of fibroblasts and numerous inflammatory cells appeared in the control group. The fibroblasts in the bioactive glass groups were large with abundant strongly basophilic cytoplasm. Prominent double nucleoli and relatively small nuclei were evident in the fibroblasts, together with increased ribosomes and rough endoplasmic reticula as well as mitochondria. From the above, it was obvious that many fibroblasts were undergoing cell mitosis. Furthermore, macrophages appeared with abundant lysosomes and mitochondria at the same time. Between the cells' liquid components, including the leaking of plasma proteins and cellulose, small amounts of collagen fibres, formed by the fibroblasts, and acid mucopolysaccharides were observed ( figure 9(a) ). In the control group, only fibroblasts could be observed. The nuclei were large and occupied almost the entire cell volume, and the organelles were sparse and undeveloped, indicating that the fibroblasts were not mature ( figure 9(b) ). On day 7, in the bioactive glass groups, numbers of inflammatory cells were sharply reduced, but fibroblasts were significantly increased and had developed enlarged nuclei. Fibroblasts contained abundant organelles, particularly more rough endoplasmic reticula (figures 9(c) and (e)). Nucleoli in the SGBG-58S and NBG-58S groups were even smaller, and the endoplasmic reticula were increased as proliferation was induced ( figure 9(c) ). There were also large numbers of new capillaries, some of which were mature and had formed vascular cavities containing red blood cells ( figure 9(d) ), while in the control group, activated inflammatory cells could be seen ( figure 9( f ) ).
Discussion
Wound healing is a dynamic, interactive process that involves soluble mediators, blood cells, extracellular matrix and parenchymal cells. The process of full-thickness wound repair involves three overlapping phases of events, generally described as inflammatory, proliferative (including matrix deposition) and remodelling phases [30] . Compared with normal skin wounds, however, healing of diabetic wounds is more complicated due to the vascular, neuropathic, immune function and biochemical abnormalities associated with diabetes [31, 32] . Experimental studies showed that these pathogenic features of the healing-impaired skin wound observed in diabetic patients could be mostly duplicated in animal models, including genetic-and chemical-induced diabetes in rats or mice [33] . In this study, we used STZ as a diabetes-inducing chemical agent to mimic the impaired wound healing in SD rats. STZ-induced diabetes results in weight loss, adrenal enlargement, thymic involution, lymphopenia and a marked impairment of wound healing [34] . STZ selectively destroys pancreatic β-cells, inhibits the Figure 9 . TEM images of skin tissue ultrathin sections of the four groups ( endoplasmic reticulum, mitochondrion, collagenous fibre, red blood cell). (a) a fibroblast from the SGBG-58S group at day 2; (b) a fibroblast from control group at day 2; (c) a fibroblast from the SGBG-58S group at day 7; (d) a new blood vessel from the SGBG-58S groups at day 7; (e) a fibroblast from the 45S5 group at day 7; ( f ) an inflammatory cell from control group at day 7.
synthesis and release of insulin and causes the onset of type 1 diabetes two or three days after a single injection of highdose STZ. We successfully induced diabetes in the rats after injection of 65 mg g −1 STZ, as shown by hyperglycemia and a slight loss of body weight. To prepare the bioactive glass ointments, Vaseline was used as the base, a material which has been widely used as an ointment substrate and a wound healing dressing in clinic for decades [35] [36] [37] . The prepared bioactive glass ointments were used to dress full-thickness wounds.
In this study, the wound healing times of the normal rats treated with bioactive glass were significantly shorter than those in the control group ( figure 3(a2) ), which indicated that the sol-gel-derived bioactive glass can accelerate the healing process of full-thickness wounds in normal rats. Recent research has shown that the melt-derived 45S5 bioactive glass has the ability to promote angiogenesis, which can be beneficial for the wound healing process. Therefore, we used the same kinds of bioactive glasses to treat full-thickness skin wounds in diabetic rats to evaluate their healing effect. As for the wound healing times and healing rates, a similar effect was observed in diabetic rats. However, the healing times of wounds in normal rats were significantly shorter than in diabetic rats due to the effects of DM. Nevertheless, we found that healing times in the bioactive glass groups were significantly shorter than in the control group (p < 0.05), as well as producing higher wound healing rates as shown in figures 3(b1) and (b2). While the NBG-58S group had a slightly shorter healing time than the 45S5 group, the healing times of the SGBG-58S group were significantly shorter than the 45S5 group, suggesting that the SGBG-58S and NBG-58S ointments may have a better effect than the 45S5 group. These results were also analysed by histological assays. Based on these results, we knew that the wound healing effect of the traditional and novel sol-gel-derived bioactive glasses (SGBG-58S, NBG-58S) was better than the melt-derived 45S5 bioactive glass.
As is well known, the first stage of wound healing is marked by an inflammatory response characterized by the infiltration of neutrophils and macrophages [38] . Neutrophils cleanse the wounded area of foreign particles and bacteria and are then extruded with the eschar or phagocytosed by macrophages whose presence can be considered as an indication that the inflammatory phase is nearing an end and that the proliferative phase is beginning [39] . During the course of our experiments, we noted that a yellow transparent membranoid substance was formed in the bioactive glass groups at about two days after surgery (figures 4(a2), (b2) and (c2)). Following H&E staining, we observed that it consisted of large numbers of inflammatory cells and bioactive glass granules as well as various secretions, suggesting that the bioactive glass may be of benefit in absorbing the exudations from the wound at the beginning.
The next phase is the proliferative phase, marked by the accumulation and proliferation of fibroblasts and the subsequent formation of granulation tissue [30] . The fibroblasts are responsible for the synthesis of collagen and other connective tissue substances, which are necessary for the formation of granulation tissue and later wound closure. In our study, in the diabetic group, many fibroblasts could be seen at day 7 in the bioactive glass groups, especially the SGBG-58S and NBG-58S groups, while relatively fewer fibroblasts appeared in the control group, which suggested that the bioactive glass could promote proliferation of fibroblasts. This was consistent with a previous study showing that bioactive glass demonstrated good biocompatibility with neonatal rat liver epithelial cells and embryonic rat fibroblasts in vitro [40] . The formation and disappearance of granulation tissue in bioactive glass groups were observed to occur faster than in the control group, though no detailed data showed this difference (figure 4). However, it was also evident from TEM studies ( figure 9 ) that a bioactive glass can promote the activity of fibroblasts, which may result in better wound healing in diabetic rats.
The formation of new blood vessels is necessary to sustain newly formed granulation tissue. Histological examination revealed that the proliferation of blood vessels in the bioactive glass groups was faster than in the control group. This may be due to the fact that a bioactive glass is able to stimulate a significant increase in the secretion of angiogenic growth factors from fibroblasts and to significantly increase vascularization into tissue engineering scaffolds, as has been reported by Keshaw et al and by Day [22, 24] . We observed that the formation of new micro-vessels was faster and more regular in the SGBG-58S group than the other groups (figure 6), which may lead to faster vascularization. From the above analysis, we assumed that the bioactive glass ointments could promote the growth of granulation tissue by accelerating the proliferation of fibroblasts and blood vessels. In the subsequent experiments, we detected two growth factorsbFGF or FGF2 and VEGF in the tissue samples.
It is known that cytokines, especially various growth factors, provide the cellular and molecular signals necessary for the normal healing process, but are deficient in diabetic wounds [1, 31] . So far, much effort has been devoted to the stimulation of an angiogenic response, among which the delivery of angiogenic factors such as FGF2, VEGF and platelet-derived growth factor has been widely employed [41] [42] [43] [44] [45] . FGF2 has many biological activities that stimulate the proliferation of fibroblasts and capillary endothelial cells, thus promoting angiogenesis and wound healing [46, 47] . VEGF is a 35-45 kDa homodimeric glycoprotein, which can stimulate the mobilization, recruitment and migration of endothelial (progenitor) cells and therefore accelerate the onset of angiogenesis. Signalling by VEGF is thought to be an essential and rate-limiting step in physiological angiogenesis, which is a multifactorial process controlled by the interplay of a large number of growth factors [48] . From immunohistochemical examination, we observed the differential expression of FGF2 and VEGF between the groups at different time points. At day 7, strong positive staining was observed in all the tissue samples. In the diabetic group, the newly formed tissues of the bioactive groups showed more abundant FGF2 and VEGF than the control group. However, the expression of FGF2 and VEGF in the normal group was less than in the diabetic group. This may be due to the faster healing of normal rats. At this stage, the diabetic rats were experiencing the late inflammatory response and early proliferation with moderate numbers of inflammatory cells, fibroblasts and regenerated blood vessels, while the normal rats had already entered into the mature proliferative phase with large numbers of fibroblasts appearing in the newly formed granulation tissue, which was confirmed by H&E staining of the different tissue samples. Compared to the control group, from the results of H&E staining and immunohistochemical examination, we knew that a bioactive glass can accelerate the healing process in both normal rats and diabetic rats. Yet 14 days after surgery, the expression of both factors had reduced to some extent, but the staining of FGF2 was still strong. At this stage, almost all the groups (except the control group of diabetic rats) had entered into the remodelling phase of wound healing, which explained the reduced expression of both the two factors and the relatively higher expression of FGF2 compared to VEGF, which was also consistent with the results of the H&E staining.
During the entire healing process, there was no strong inflammatory response in any of the rats towards the bioactive glass. We could see from microscopic examination that some of the bioactive glass particles had been phagocytosed by the macrophages (figure 5) several days after surgery, while others had been excreted from the wounds. As we re-applied the bioactive glass every other day, we assumed that before it was excreted or phagocytosed, the bioactive glass had already played an important role in stimulating the expression of several growth factors such as VEGF and FGF2, which are beneficial for wound healing.
From these results, we can see that wound healing in normal rats is better than in diabetic rats, as reflected in the shorter wound healing times, faster and stronger expression of VEGF and FGF2. However, compared to the control group of diabetic rats, the wound healing process in diabetic rats treated with bioactive glass was faster and it was similar to the healing process in normal rats. We also know that bioactive glass, especially sol-gel-derived bioactive glass, can accelerate the wound healing process in both normal and diabetic rats.
SEM photomicrographs of the bioactive glass showed that both SGBG-58S and NBG-58S have a porous microstructure, while 45S5 has an impacted microstructure ( figure 1) ; thus, the bioactivity of SGBG-58S and NBG-58S is higher than that of 45S5 [49] . Using histological examinations and TEM observations, we observed that the proliferation and activity of fibroblasts, as well as vascularization, were improved in the SGBG-58S and NBG-58S groups compared to the 45S5 group, which was also consistent with the wound healing time. This could be a result of the different structures of the three types of bioactive glasses. Because of their microstructures and larger surface area [49] , SGBG-58S and NBG-58S could adsorb fibroblasts, epidermal cells and all types of growth factors (such as VEGF and FGF2) and other proteins to help the cutaneous wound healing process [19, 50] .
Conclusion
The bioactive glass can promote the proliferation and activity of fibroblasts and accelerate the process of vascularization, leading to the promotion of growth of granulation tissue. Also, the production of two growth factors, VEGF and FGF2, which are beneficial for wound healing, was also stimulated during the healing process. As a result, bioactive glass improves wound healing in both normal and diabetic rats. Compared with the melt-derived 45S5 bioactive glass, sol-gel-derived bioactive glasses (SGBG-58S and NBG-58S) promoted wound healing more quickly and efficiently because of their special structures. In conclusion, the results of this study raise the possibility of using a bioactive glass to facilitate the healing of skin wounds.
